Adiyogi Multispeciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 4.21 Cr
- Paid Up Capital ₹ 4.21 Cr
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.10 M
About Adiyogi Multispeciality Hospital
Adiyogi Multispeciality Hospital Private Limited (AMHPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 September 2021 (Three years and five months 5 days old ). Its registered office is in Dewas, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.21 Cr and a paid-up capital of Rs 4.21 Cr.
The company currently has active open charges totaling ₹3.10 M.
Ashwin Songara and Laxmi Tomar serve as directors at the Company.
Company Details
-
Location
Dewas, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85100MP2021PTC057406
-
Company No.
057406
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Sep 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Adiyogi Multispeciality Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwin Songara
|
Director | 09-Sep-2021 | Current |
|
Laxmi Tomar
|
Director | 09-Sep-2021 | Current |
Financial Performance of Adiyogi Multispeciality Hospital.
Adiyogi Multispeciality Hospital Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adiyogi Multispeciality Hospital?
In 2023, Adiyogi Multispeciality Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.31 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.31 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jan 2022 | State Bank Of India | ₹3.10 M | Open |
How Many Employees Work at Adiyogi Multispeciality Hospital?
Adiyogi Multispeciality Hospital has a workforce of 21 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adiyogi Multispeciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adiyogi Multispeciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.